Review: PeckPerk Smart Solar-Powered Bird Feeder made me a nature lover
I am now a bird lover, a twitcher if you will, and it's all down to the PeckPerk Smart Solar-Powered Bird Feeder. It's a hi-tech feeder for your garden with a camera that takes video of your feathered friends coming in to have a snack, and share them with you via wifi.
The all-color night vision means you can enjoy 2K UHD clarity at any time. Paired with the (rather basic) mobile app, it will give you real-time alerts to anyone visiting.
Set-up is pretty easy. You are given the tools to fix the teardrop-shaped feeder wherever you like, be that poles, walls, fences, or trees. The shape is inspired by a weaver bird nest and is fronted by a perch styled to look like twigs. A tip on installation, it's best not have too many flowers or anything that moves in the wind within the camera's view as the movement will set it off.
It comes with a small solar panel that keeps the battery topped up. Certainly, during the recent sunny spell, it's been kept at full charge for weeks.
One of the biggest pluses is that it gives you free cloud storage on a rolling basis. You can share the pix to keep them, or even install an SD card for extra backup.
You can spend a few pounds a month to unlock the device's AI-powered bird recognition system that says it can ID more than 10,000 species. To be honest, this is the one feature that didn't work for me, and it was always telling me I wasn't looking at a picture of a bird. Out of the two birds it did identify, it said one was a bird only found in North America which hinted at a US bias. A product support request went unanswered. VIP status will also get you enhanced cloud services.
It also packs a squirrel deterrent system, which emits a warning tone to scare away unwanted visitors, ensuring that only birds access the feed.
Once I had it all set up and filled with bird food it did take a few days of crossed-fingers wondering if any bird was going to show up but after a while they did and we now have several regulars who turn up day-in. day-out.
This has been the most fun, and my children have also got really into bird watching as a result! I'd say despite a few quibbles, the PeckPerk has been one of the most enjoyable tech gadgets I have ever tested.
What users say
"I've been using this smart bird feeder with a camera for several months now, and it has completely transformed my birdwatching experience! Whether you're a nature lover, educator, or business looking to engage customers, this feeder goes beyond expectations."
"This is easy to set up, if you follow the instructions. It is not all intuitive, so don't try to install without them. Everything is high quality and very well constructed. We have not seen any birds yet, but have got lots of notifications for big bugs flying by. It has alerted us to squirrels when there have been no squirrels present. What it records is high quality. And the app could use a couple of UI improvements, but it works nicely overall."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
US stocks tend to gain around Fed's Jackson Hole summer conference, analysis shows
By Lewis Krauskopf NEW YORK (Reuters) -U.S. stocks have tended to fare well around the Federal Reserve's Jackson Hole gathering in August, according to a historical analysis from DataTrek Research, although the market has seen sizable moves in both directions in recent years. The Fed's annual Wyoming research conference is set for Thursday through Saturday, and Chair Jerome Powell's speech on Friday is expected to be the main event for markets. DataTrek looked at the benchmark S&P 500 in the five trading days before and after the Fed chair's speech since 2010. The index gained an average of 0.9% over the period, with the bulk after the speech. "This suggests that markets get incremental clarity from the chair's speech, which in turn boosts equity valuations," Nicholas Colas, DataTrek's co-founder, said in a research note. This year, the S&P 500 has slipped in the lead-up to the speech so far, Colas said in the note published early Tuesday. "This goes against the usual pattern, so we would not be surprised to see the index rally modestly through Thursday," he said. One notable exception to the trend was in 2022, when the index slumped 7.4% in the 10-day period. That year at Jackson Hole, Powell warned of slower growth as the Fed fought high inflation. The S&P 500 fell over 19% for the full year 2022 as the Fed raised interest rates. In 2023, the index gained 3.3% in the studied period. DataTrek noted the S&P 500 fell in 2013 and 2015 when Fed chairs Ben Bernanke and Janet Yellen did not attend the symposium. This year, investors are eager to see if Powell reinforces expectations of a central bank interest rate cut at its September 16-17 meeting. Recent weak labor market data bolstered those expectations. Fed Fund futures on Tuesday were pricing in an 84% chance of such a move, according to LSEG data.
Yahoo
7 minutes ago
- Yahoo
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma
JUPITER, Fla., Aug. 19, 2025 /PRNewswire/ -- Myosin Therapeutics, a biotechnology company developing novel therapies for aggressive cancers, today announced it has been awarded a $4.5M Phase IIB Bridge Award from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) program. The funding will support Myosin Therapeutic's Phase I STAR-GBM dose escalation and expansion trial of MT-125, a first-in-class novel small molecule therapeutic being evaluated in patients with newly diagnosed, MGMT unmethylated glioblastoma. Glioblastoma remains among the most lethal cancers, with median survival measured in months. MT-125 targets non-muscle myosin II, a critical driver of tumor cell invasion, proliferation and treatment resistance, representing a novel therapeutic approach that is distinct from existing standards of care. The STAR-GBM trial will assess the safety, tolerability, and pharmacokinetics of MT-125 in this patient population with significant unmet need. Exploratory endpoints include measures of efficacy, including progression-free survival and overall survival. The NCI SBIR program is one of the most competitive federal funding mechanisms for cancer-focused innovation, providing support to small businesses with technologies that have strong scientific merit, commercial potential, and a clear path to clinical impact. Bridge Awards, which require that matching funds from private capital be raised first, are reserved for companies with promising, later-stage projects that have already demonstrated significant technical progress and the potential to attract substantial private investment. "The NCI Bridge Award was perfectly timed to support our STAR-GBM trial, for which patient enrollment is set to begin in November," said Dr. Courtney Miller, co-founder and CEO of Myosin Therapeutics. "It will enable us to generate the data needed to position the program for later-stage development, potential partnerships, and future expansion into a wider range of patients. Our ultimate goal is to deliver a transformative treatment option for patients who currently face limited or inadequate therapeutic choices." About Myosin TherapeuticsMyosin Therapeutics is a Jupiter, FL-based biotechnology company spun out of The Wertheim UF Scripps Institute (formerly Scripps Research, Florida). The company is focused on developing therapies for neuroscience and oncology indications using a platform that targets molecular nanomotor proteins. For more information, visit Contact: contact@ View original content to download multimedia: SOURCE Myosin Therapeutics Inc.
Yahoo
7 minutes ago
- Yahoo
6 Chiefs won't practice on Tuesday; Steve Spagnuolo weighs in
Ahead of their practice at their home facility at the Truman Sports Complex on Tuesday, the Kansas City Chiefs listed six players who would not take the field due to injury or illness: linebacker Jack Cochrane (knee bruise), offensive lineman Ethan Driskell (appendectomy), safety Mike Edwards (hamstring), cornerback Nazeeh Johnson (shoulder), defensive tackle Omarr Norman-Lott (ankle) and wide receiver Jalen Royals (knee). Late Monday afternoon, Kansas City placed defensive end Felix Anudike-Uzomah on the Reserve/Injured list. Even though he is practicing, cornerback Kristian Fulton has yet to play in a preseason game as he recovers from offseason knee surgery. 'Well, the unknown is Kristian right now because we haven't had him out there,' said defensive coordinator Steve Spagnuolo. 'Jaylen [Watson] has missed some time, and now we've got [Johnson], who is a little dinged up. More than any group on the defense, that back end has to have a lot of continuity, and that comes with reps. So with a couple of different moving pieces, there's a little bit of concern there, so hopefully we can start to gel that together.' The Chiefs play their final game of the 2025 preseason against the Chicago Bears at home on Friday at 7:20 p.m. Arrowhead Time. Chiefs head coach Andy Reid has already confirmed that the starters will see playing time.
